샘플 요청 목록

 카트 문의
시장보고서
상품코드
1786584

세계의 불임치료 관광 시장

Fertility Tourism
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 287 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

불임치료 관광 세계 시장은 2030년까지 53억 달러에 달할 전망

2024년에 15억 달러로 추정되는 불임치료 관광 세계 시장은 2024년부터 2030년까지 CAGR 23.1%로 성장하여 2030년에는 53억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 기증 난자 치료는 CAGR 26.5%를 기록하며 분석 기간 종료시에는 21억 달러에 달할 것으로 예측됩니다. 자가 난자 치료에 의한 체외수정(IVF With Own Egg Treatment) 부문의 성장률은 분석 기간 동안 CAGR 22.3%로 추정됩니다.

미국 시장은 4억 1,500만 달러로 추정, 중국은 CAGR 31.2%로 성장할 것으로 예측

미국의 불임치료 관광 시장은 2024년에 4억 1,500만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 13억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 31.2%가 됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 18.2%와 20.9%로 예측됩니다. 유럽에서는 독일이 CAGR 약 19.5%로 성장할 것으로 예측됩니다.

세계의 불임치료 관광 시장 - 주요 동향과 촉진요인 정리

왜 불임치료 관광이 생식 희망의 국경을 넘나드는 생명줄로 떠오르는가?

체외수정, 난자 제공, 대리모, 정자 제공 등 보조생식술(ART)을 받기 위해 개인이나 부부가 해외로 여행을 떠나면서 생식의료관광(생식의료 또는 국경을 초월한 생식의료라고도 함)이 크게 성장하고 있습니다. 비용, 가용성, 법적 프레임워크, 성공률의 격차에 힘 입어, 이러한 세계적 움직임은 의료 접근성과 해외여행을 결합한 의료관광의 하위 부문의 번영을 가져왔습니다. 상업적 대리모 금지, 연령 및 혼인관계 제한, LGBTQ+의 가족 구성에 대한 제약 등 자국 내 규제로 인해 보다 관용적인 여행지에서 치료를 받아야 하는 경우가 많아지면서 많은 사람들이 퍼티티 투어리즘을 이용하고 있습니다. 인도, 우크라이나, 스페인, 그리스, 멕시코, 미국 등의 국가들이 포괄적이고 비교적 저렴한 불임 치료 서비스를 제공하는 중요한 거점으로 부상하고 있으며, 서유럽, 북미, 중동, 아시아에서 환자를 유치하고 있습니다. 감정적, 경제적 위험이 높고, 양질의 의료와 신중함, 짧은 대기 시간, 법적 보호를 결합할 수 있기 때문에 시설 관광은 전 세계 생식 건강 상황에서 점점 더 요구되는 솔루션이 되고 있습니다.

불임치료 관광의 핫스팟을 형성하는 법적, 윤리적 상황은 어떤가?

법적 프레임워크와 윤리적 고려사항은 전 세계 의료관광 생태계의 핵심이며, 종종 환자가 치료를 위해 여행하는 장소를 결정합니다. 익명의 난자 및 정자 제공, 임신 중 대리모, 의료 목적 외 배아 동결 등 자유주의적인 ART 규제를 가진 국가는 해외 환자들에게 가장 중요한 선택지가 되고 있습니다. 예를 들어, 스페인과 체코는 법적 익명성과 기증자의 가용성으로 인해 기증자 난자 체외수정을 선호하며, 멕시코와 콜롬비아는 저렴한 대리모 옵션과 환자 친화적인 법률로 인기를 얻고 있습니다. 반면 독일, 프랑스, 중국, 중동 일부 지역 등에서는 규제가 엄격하거나 규제가 발전하고 있기 때문에 개인들은 해외로 서비스를 요청하고 있습니다. 특히 상업적 대리모, 착취, 사전 동의에 대한 윤리적 우려는 인도와 태국과 같은 국가에서 개혁을 촉구하고 외국인에 대한 일부 서비스를 폐쇄하고 더 엄격한 감시를 도입하는 결과를 낳고 있습니다. 이러한 법제도의 변화는 불임클리닉과 대리모 기관에 컴플라이언스, 국경 간 친권의 법적 승인, 대리모와 기증자의 윤리적 처우 등 도전과 기회를 모두 창출하고 있습니다. 불임 치료 기관을 선택할 때, 환자들은 저렴한 가격뿐만 아니라 법적 명확성, 의료 수준, 윤리적 안전장치를 우선시하는 경향이 점점 더 강해지고 있습니다.

인구통계, 사회적 규범, 그리고 접근성이 시장 확대에 어떤 역할을 하고 있는가?

사회 규범의 변화, 인구통계학적 변화, 생식 관련 이슈는 전 세계적으로 시설 관광에 대한 수요를 촉진하고 있습니다. 생활습관 요인, 출산 지연, 환경적 영향, 만성질환 비율 증가 등으로 인한 불임율 증가는 국경을 넘어 생식 의료를 찾는 개인들을 자극하고 있습니다. 한편, 동성 커플, 선택에 의한 편부모, 부모가 되기를 원하는 노인 등 기존과 다른 가족 형태가 수용되고 있어 ART 서비스의 수요 기반이 확대되고 있습니다. 이러한 환자 그룹은 대부분 자국에서 법적 또는 제도적 장벽에 직면하고 있기 때문에 불임 치료가 쉬운 국가가 더 매력적으로 느껴집니다. 의료관광객을 위한 간소화된 비자 절차, 다국어 불임치료 코디네이터, 번들링된 치료 패키지 등 접근성 향상으로 물류적 장애물을 제거했습니다. 원격의료, 원격진료, 디지털 불임 모니터링 앱의 기술 발전은 환자가 멀리서부터 페이슨트 여정을 시작할 수 있도록 돕고, 초기 장벽을 낮추고 투명성을 높이고 있습니다. 또한, 소셜 미디어, 온라인 포럼, 불임 치료 인플루언서들은 전 세계의 선택에 대한 인식을 높이고, 피어 투 피어 학습과 증언 중심의 의사결정을 가능하게 합니다. 생식에 대한 열망이 점점 더 국경을 넘나드는 가운데, 이러한 사회적, 인구통계학적 변화는 시설 관광을 개인적 해결책이자 성장하는 세계 산업으로 자리매김하고 있습니다.

불임치료 관광 세계 시장의 성장 촉진요인은 무엇일까?

의료의 세계화, 비용 격차, 인구통계학적 변화, 국경을 초월한 법적 차이에 기반한 여러 요인에 의해 불임치료 관광 시장의 성장이 견인되고 있습니다. 인도, 우크라이나, 그루지야와 같은 국가에서의 체외수정과 대리모 출산은 여행비와 숙박비를 고려해도 미국이나 영국보다 최대 70% 저렴합니다. 동시에, 캐나다나 영국과 같은 국가의 공공 의료 시스템에서 ART 서비스 대기 시간이 길기 때문에 환자들은 해외에서 더 빨리 접근하기를 원하고 있습니다. 의료관광에 대한 정부의 전략적 지원과 더불어 여행지 국가의 ART법 자유화, 인프라 및 국제 환자 서비스 개선을 통한 성장에 기여하고 있습니다. 불임 환자 증가, 특히 도시 인구 증가로 인해 환자층이 확대되는 한편, 불임 치료 실험실의 기술 표준화로 인해 평판이 좋은 국제 클리닉에서 일관된 성공률을 보장하고 있습니다. 또한, 불임 치료 대리점, 컨시어지 서비스, 국제 대리모 네트워크의 존재감이 커지고 있으며, 여행, 법적 계약, 치료 후 관리 등 엔드 투 엔드 조정이 원활하게 이루어지고 있습니다. 마지막으로, 옹호 단체, 인플루언서, 유명 인사들이 지지하는 생식 문제에 대한 개방적인 태도는 ART의 낙인을 없애고, 국경을 초월한 수요를 창출하며, 생식 건강 관리의 미래에서 필수적인 솔루션으로서의 지위를 강화하고 있습니다.

부문

치료(기증 난자 치료, 자가 난자에 의한 체외수정 치료, 대리모 출산 치료, 기증 배아 치료, 정자 제공 치료), 연령층(18-24, 25-34, 35-44, 45-54)

조사 대상 기업 사례

  • Bangkok Hospital
  • Barbados Fertility Centre
  • BioTexCom Center for Human Reproduction
  • Bourn Hall Clinic
  • Clinica Tambre
  • Copenhagen Fertility Center
  • Dunya IVF Clinic
  • Embryolab Fertility Clinic
  • Fertility Associates
  • Fertility Center Mexico
  • Fertility First
  • GREFI(Grupo de Fertilidad y Ginecologia)
  • IVI Fertility
  • Life Clinic Athens
  • Medfem Fertility Clinic
  • NewLife IVF
  • North Cyprus IVF Centre
  • Nova IVF Fertility
  • Reprofit International
  • Sanatorium HELIOS

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴로 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.14

Global Fertility Tourism Market to Reach US$5.3 Billion by 2030

The global market for Fertility Tourism estimated at US$1.5 Billion in the year 2024, is expected to reach US$5.3 Billion by 2030, growing at a CAGR of 23.1% over the analysis period 2024-2030. Donor Egg Treatment, one of the segments analyzed in the report, is expected to record a 26.5% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the IVF With Own Egg Treatment segment is estimated at 22.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$415.0 Million While China is Forecast to Grow at 31.2% CAGR

The Fertility Tourism market in the U.S. is estimated at US$415.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 31.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 18.2% and 20.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 19.5% CAGR.

Global Fertility Tourism Market - Key Trends & Drivers Summarized

Why Is Fertility Tourism Emerging as a Cross-Border Lifeline for Reproductive Hope?

Fertility tourism-also known as reproductive or cross-border reproductive care-is witnessing significant growth as individuals and couples travel abroad in pursuit of assisted reproductive technologies (ART) like IVF, egg donation, surrogacy, and sperm donation. Driven by disparities in cost, availability, legal frameworks, and success rates, this global movement is giving rise to a thriving medical tourism sub-sector that blends healthcare access with international travel. Many turn to fertility tourism due to restrictive regulations in their home countries-such as bans on commercial surrogacy, age or marital status limits, or constraints on LGBTQ+ family-building-compelling them to seek treatment in more permissive destinations. Countries like India, Ukraine, Spain, Greece, Mexico, and the United States have emerged as key hubs offering comprehensive and comparatively affordable fertility services, attracting patients from Western Europe, North America, the Middle East, and Asia. The emotional and financial stakes are high, and the ability to combine high-quality medical care with discretion, reduced waiting times, and legal protection has made fertility tourism an increasingly sought-after solution in the global reproductive health landscape.

How Are Legal and Ethical Landscapes Shaping Fertility Tourism Hotspots?

Legal frameworks and ethical considerations are central to the global fertility tourism ecosystem, often determining where patients choose to travel for treatment. Countries with liberal ART regulations-allowing procedures like anonymous egg/sperm donation, gestational surrogacy, and embryo freezing for non-medical reasons-are becoming top choices for international patients. For instance, Spain and the Czech Republic are preferred for donor egg IVF due to legal anonymity and donor availability, while Mexico and Colombia have gained traction for affordable surrogacy options and patient-friendly laws. Meanwhile, restrictive or evolving regulations in countries like Germany, France, China, and parts of the Middle East are pushing individuals to seek services abroad. Ethical concerns-especially around commercial surrogacy, exploitation, and informed consent-have prompted reforms in countries like India and Thailand, leading to the closure of some services to foreigners or the introduction of stricter oversight. These shifting legal terrains create both challenges and opportunities for fertility clinics and agencies, who must navigate compliance, cross-border legal recognition of parental rights, and the ethical treatment of surrogates and donors. Increasingly, patients are prioritizing not just affordability, but also legal clarity, medical standards, and ethical safeguards when choosing a destination for fertility care.

What Role Are Demographics, Social Norms, and Accessibility Playing in Market Expansion?

Changing social norms, demographic trends, and reproductive challenges are fueling global demand for fertility tourism. The rise in infertility rates-driven by lifestyle factors, delayed childbearing, environmental influences, and rising rates of chronic conditions-is prompting individuals to explore reproductive care across borders. Meanwhile, growing acceptance of non-traditional family structures, including same-sex couples, single parents by choice, and older individuals seeking parenthood, is widening the demand base for ART services. Many of these patient groups face legal or institutional barriers in their home countries, making fertility-friendly nations more attractive. Accessibility improvements, such as streamlined visa processes for medical tourists, multilingual fertility coordinators, and bundled treatment packages, are also removing logistical obstacles. Technological advancements in telehealth, remote consultations, and digital fertility monitoring apps are helping patients begin their journey from afar, reducing initial barriers and enhancing transparency. Furthermore, social media, online forums, and fertility influencers are increasing awareness about global options, enabling peer-to-peer learning and testimonial-driven decision-making. As reproductive aspirations increasingly transcend borders, these social and demographic shifts are establishing fertility tourism as both a personal solution and a growing global industry.

What Are the Core Growth Drivers Accelerating the Fertility Tourism Market Globally?

The growth in the Fertility Tourism market is driven by several factors rooted in medical globalization, cost differentials, demographic shifts, and legal divergence across borders. One of the primary drivers is the significant variation in treatment costs-IVF and surrogacy procedures in countries like India, Ukraine, and Georgia can be up to 70% less expensive than in the U.S. or U.K., even after accounting for travel and accommodation. At the same time, long waiting periods for ART services in public healthcare systems across countries like Canada and the U.K. are prompting patients to seek faster access abroad. The liberalization of ART laws in destination countries, alongside strategic government support for medical tourism, is also contributing to growth by improving infrastructure and international patient services. Rising infertility prevalence, particularly in urban populations, is expanding the patient pool, while technological standardization in fertility labs ensures consistent success rates across reputable international clinics. Additionally, the growing presence of fertility agencies, concierge services, and international surrogacy networks is facilitating smoother end-to-end coordination of travel, legal contracts, and post-treatment care. Finally, increased openness around reproductive challenges-supported by advocacy groups, influencers, and celebrities-has de-stigmatized ART and created a demand surge that crosses national borders, reinforcing fertility tourism’s status as a vital solution in the future of reproductive healthcare.

SCOPE OF STUDY:

The report analyzes the Fertility Tourism market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment (Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment, Sperm Donation Treatment); Age Group (18-24, 25-34, 35-44, 45-54)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Bangkok Hospital
  • Barbados Fertility Centre
  • BioTexCom Center for Human Reproduction
  • Bourn Hall Clinic
  • Clinica Tambre
  • Copenhagen Fertility Center
  • Dunya IVF Clinic
  • Embryolab Fertility Clinic
  • Fertility Associates
  • Fertility Center Mexico
  • Fertility First
  • GREFI (Grupo de Fertilidad y Ginecologia)
  • IVI Fertility
  • Life Clinic Athens
  • Medfem Fertility Clinic
  • NewLife IVF
  • North Cyprus IVF Centre
  • Nova IVF Fertility
  • Reprofit International
  • Sanatorium HELIOS

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Fertility Tourism - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • High Cost of Fertility Treatments in Developed Nations Throws the Spotlight on Cross-Border Reproductive Options
    • Long Wait Times and Access Barriers Spur Demand for Affordable and Timely Fertility Care Abroad
    • Expanding Legalization of Surrogacy and Egg Donation in Select Countries Strengthens the Business Case for Fertility Tourism
    • Favorable Government Policies and Medical Infrastructure in Destination Countries Propel Growth of Reproductive Travel
    • Growing Awareness Through Online Communities and Medical Tourism Platforms Drives Patient Mobility Across Borders
    • Increasing Demand for Donor Gametes and Advanced ART Techniques Generates Opportunities in Specialized Fertility Clinics Abroad
    • LGBTQ+ and Single Parent Family Planning Needs Expand the Addressable Market for Inclusive Fertility Tourism Services
    • Rising Infertility Rates and Delayed Parenthood Trends Sustain Global Demand for Accessible Reproductive Solutions
    • Global Accreditation and Quality Certifications Build Trust and Standardization Across Cross-Border Clinics
    • Cultural Acceptance and Language Support Services Enhance Patient Comfort in Foreign Treatment Destinations
    • Technological Advancements in Remote Fertility Consultations Drive Pre- and Post-Treatment Integration Across Geographies
    • Ethical and Legal Complexities Around Surrogacy and Embryo Transport Create Regulatory Hurdles but Also Push for Reform
    • Rising Interest in Egg Freezing and Fertility Preservation Fuels Medical Travel Among Career-Oriented Individuals
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Fertility Tourism Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Fertility Tourism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Fertility Tourism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Fertility Tourism by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Donor Egg Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Donor Egg Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Donor Egg Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for IVF With Own Egg Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for IVF With Own Egg Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for IVF With Own Egg Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Surrogacy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Surrogacy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Surrogacy Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Donor Embryo Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Donor Embryo Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Donor Embryo Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Sperm Donation Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Sperm Donation Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Sperm Donation Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for 18-24 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for 18-24 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for 18-24 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for 25-34 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for 25-34 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for 25-34 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for 35-44 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for 35-44 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for 35-44 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for 45-54 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for 45-54 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for 45-54 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • JAPAN
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • CHINA
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • EUROPE
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Fertility Tourism by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Fertility Tourism by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Fertility Tourism by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • FRANCE
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • GERMANY
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Spain 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Russia 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Tourism by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Fertility Tourism by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Fertility Tourism by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Australia 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • INDIA
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: India 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: South Korea 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Fertility Tourism by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Fertility Tourism by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Fertility Tourism by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Argentina 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Brazil 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Mexico 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Fertility Tourism by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Fertility Tourism by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Fertility Tourism by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Iran 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Israel 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: UAE 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • AFRICA
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Africa 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제